SRR1418127
GTEX
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- GTEX
- cancer_type_detailed
- —
- subtype
- —
- cancer_type
- GTEX
- sex
- Male
GSVA pathway preview (0 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
7 twins match this tumor's tissue · 3 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | SRR1375976 | GTEX | — | 0.972 |
| 2 | SRR1435484 | GTEX | — | 0.965 |
| 3 | BS_C7N3J4NW | high-grade glioma | — | 0.962 |
| 4 | SRR1314958 | GTEX | — | 0.962 |
| 5 | SRR614900 | GTEX | — | 0.959 |
| 6 | BS_3T6X4BPC | DNET | — | 0.958 |
| 7 | BS_KPT2WPHW | Ganglioglioma | — | 0.954 |
| 8 | SRR1407134 | GTEX | — | 0.954 |
| 9 | SRR1477080 | GTEX | — | 0.953 |
| 10 | SRR1388378 | GTEX | — | 0.953 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 16 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| KRAS_SIGNALING_DN | 0.494 | Remibrutinib | — uncovered |
| PANCREAS_BETA_CELLS | 0.434 | Cobimetinib | — uncovered |
| APICAL_SURFACE | 0.296 | Temsirolimus | — uncovered |
| SPERMATOGENESIS | 0.255 | Inavolisib | — uncovered |
| ANGIOGENESIS | 0.217 | Remibrutinib | — uncovered |
| HEDGEHOG_SIGNALING | 0.206 | Inavolisib | — uncovered |
| MYOGENESIS | 0.187 | Inavolisib | — uncovered |
| UV_RESPONSE_DN | 0.180 | Inavolisib | — uncovered |
| ESTROGEN_RESPONSE_EARLY | 0.164 | Inavolisib | — uncovered |
| ESTROGEN_RESPONSE_LATE | 0.160 | Idelalisib | — uncovered |
| KRAS_SIGNALING_UP | 0.122 | Inavolisib | — uncovered |
| BILE_ACID_METABOLISM | 0.115 | Inavolisib | — uncovered |
| APICAL_JUNCTION | 0.105 | Inavolisib | — uncovered |
| EPITHELIAL_MESENCHYMAL_TRANSITION | 0.039 | Inavolisib | — uncovered |
| XENOBIOTIC_METABOLISM | 0.038 | Inavolisib | — uncovered |
| COAGULATION | 0.007 | Binimetinib | — uncovered |